Alpha Omega Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Alpha Omega Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-505	Closed	-$55K	–	373
2019 Q2	$55K	Hold	505	–	–	0.02%	233
2019 Q1	$56K	Hold	505	–	–	0.03%	230
2018 Q4	$49K	Sell	505 -95	-16%	-$10.1K	0.02%	223
2018 Q3	$73K	Hold	600	–	–	0.03%	199
2018 Q2	$66K	Hold	600	–	–	0.03%	204
2018 Q1	$64K	Hold	600	–	–	0.03%	195
2017 Q4	$64K	Hold	600	–	–	0.03%	201
2017 Q3	$67K	Hold	600	–	–	0.03%	208
2017 Q2	$62K	Hold	600	–	–	0.03%	215
2017 Q1	$59K	Hold	600	–	–	0.03%	217
2016 Q4	$53K	Buy	+600	New	+$54.6K	0.03%	225

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Alpha Omega Wealth Management's IBB Position: Q3 2019 in Review

Alpha Omega Wealth Management sold out of iShares Biotechnology ETF (IBB) in Q3 2019, closing a stake of 505 shares — an estimated $55K sold.

Alpha Omega Wealth Management first reported a position in IBB in Q4 2016 and held it in 11 quarters. The position peaked at $73K in Q3 2018. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

Alpha Omega Wealth Management reported no remaining iShares Biotechnology ETF position as of Q3 2019 after selling out during the quarter.
Alpha Omega Wealth Management sold 505 iShares Biotechnology ETF shares in Q3 2019, an estimated $55K.
Alpha Omega Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 11 quarters.
Alpha Omega Wealth Management's iShares Biotechnology ETF position peaked at $73K in Q3 2018.
597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Alpha Omega Wealth Management's 13F filing for Q3 2019, filed 12 Nov 2019.